The role of dopamine and serotonin receptors in the mediation of the ethanol interoceptive cue

1988 ◽  
Vol 30 (1) ◽  
pp. 55-64 ◽  
Author(s):  
Steven A. Signs ◽  
Martin D. Schechter
2016 ◽  
Vol 101 (8) ◽  
pp. 1064-1074 ◽  
Author(s):  
R. Forcén ◽  
E. Latorre ◽  
J. Pardo ◽  
A. I. Alcalde ◽  
M. D. Murillo ◽  
...  

Synapse ◽  
1990 ◽  
Vol 6 (2) ◽  
pp. 146-153 ◽  
Author(s):  
Steven J. O'Dell ◽  
Gerald J. Lahoste ◽  
Clifford B. Widmark ◽  
Raymond M. Shapiro ◽  
Steven G. Potkin ◽  
...  

2011 ◽  
pp. 15-25 ◽  
Author(s):  
M. PYTLIAK ◽  
V. VARGOVÁ ◽  
V. MECHÍROVÁ ◽  
M. FELŠÖCI

Serotonin (5-hydroxytryptamine) is an ubiquitary monoamine acting as one of the neurotransmitters at synapses of nerve cells. Serotonin acts through several receptor types and subtypes. The profusion of 5-HT receptors should eventually allow a better understanding of the different and complex processes in which serotonin is involved. Its role is expected in the etiology of several diseases, including depression, schizophrenia, anxiety and panic disorders, migraine, hypertension, pulmonary hypertension, eating disorders, vomiting and irritable bowel syndromes. In the past 20 years, seven distinct families of 5-HT receptors have been identified and various subpopulations have been described for several of them. Increasing number of 5-HT receptors has made it difficult to unravel the role of 5-HT receptor subpopulations due to the lack of suitable selective agents. The present review describes the different populations and nomenclature of recently discovered 5-HT receptors and their pharmacological relevance.


2003 ◽  
Vol 49 (6) ◽  
pp. 53-56
Author(s):  
T. G. Amstislavskaya ◽  
N. K. Popova

Placement of a sexually receptive female mouse behind a partition that prevents physical contacts, but permits it to see and smell caused an increase in the blood levels of testosterone in male mice. The selective 5-HTIA-serotonin receptor agonist 08-OH- DPAT (0.1 mg/kg) and the mixed 5-HTIA/IB agonist eltoprazine, 3.0 and 10.0 mg/kg, blocked the activating effect of female exposure on the male pituitary-testicular system. The 5-HT/-receptor agonist p-MPPI (0.2 mg/kg) prevented the inhibitory effects of 8-OH-DPATand eltoprazine. The 5-HT/B-receptor agonist CGS- 12066A (1.0 and 2.0 mg/kg) exerted no effect while the mixed 5-HTIB/2C-receptor agonist TFMPP (5.2 mg/kg) inhibited a female-induced increase in the levels of male blood testosterone. The 5-HT/-receptor agonist keranserin (1.0 and 2.0 mg/kg) prevented a female-induced increase in the levels of testosterone. The 5-HT3-receptor agonist ondansetron (0.05 and 0.1 mg/kg) elevated the baseline level of plasma testosterone, but blocked receptive female-induced activation of the male hypothalamic-pituitary-testicular system (HPTS). It is concluded that 5-HTIA-receptors are involved in the control of male sexual activation. At the same time different types and even subtypes of the same type of 5-HT-receptors produce varying inhibitory and activating effects on the receptive female-induced activation of HPTS. Blocking of the female-induced activation of HPTS seems to be realized by involving 5-HTu- and 5-HT2C-receptors and its activation occurs with the participation of 5-HT^- and 5- HT3-receptors.


1985 ◽  
Vol 99 (6) ◽  
pp. 754-756 ◽  
Author(s):  
A. M. Zharkovskii ◽  
N. E. Klassen ◽  
T. A. Zharkovskaya

Sign in / Sign up

Export Citation Format

Share Document